Avalo Therapeutics Inc
XNAS: AVTX
Avalo Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also incl...
Read More
9.29
-0.05
(-0.54%)
76,552
XNAS Volume
XNAS 29 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Avalo Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..